Case Paper Study: Laparoscopic vs. Open (Abdominal) Hysterectomy

Operative Outcomes and Complications

1. Introduction

2. Classification of Hysterectomy Routes

According to Berek & Novak's Gynecology: "Increased utilization of the minimally invasive approach to hysterectomy by laparoscopy or robotic assistance has decreased hysterectomy rates by laparotomy. Vaginal hysterectomy rates have been stable. There are no specific criteria that can be used to determine the route of hysterectomy. The route chosen should be based on the individual patient, but the vaginal approach is preferred, when feasible."

3. Patient Selection and Contraindications

Factors Influencing Route Choice

• Vaginal shape and accessibility to the uterus
• Uterine size and shape
• Extent of extrauterine disease and need for concurrent procedures
• Prior surgical history (adhesions, midline incisions)
• Anesthesia issues, morbid obesity, hip disease
• Surgeon competence and available support facilities
• Preference of the informed patient

Contraindications to Laparoscopic Approach (Relative)

• Medical/anesthetic disorders preventing adequate pneumoperitoneum or ventilation
• Extensive dense pelvic-abdominal adhesions
• Very large uterine size limiting access to uterine vessels
• Note: Obesity is NOT a contraindication - the increased morbidity of laparotomy in high-BMI patients can be minimized with laparoscopy

4. Operative Outcomes: Head-to-Head Comparison

4.1 Return to Normal Activities

If return to activities after AH is assumed to be 37 days, then after LH it would be 22-25 days. (Cochrane 2023)

4.2 Operative Time

4.3 Blood Loss

4.4 Hospital Length of Stay (LOS)

5. Complications: Detailed Analysis

5.1 Overall Complication Rates

• Robotic vs. open: OR 0.42 (95% CI: 0.27 to 0.66; p = 0.0001) favoring minimally invasive surgery (Lenfant et al., J Robot Surg, 2023, PMID 37856058)
• Intraoperative morbidity: LH vs. AH RR 0.90 (0.80-1.02) - lower in LH (Kampers 2022)
• Postoperative morbidity: No significant difference between routes (Kampers 2022)

5.2 Urinary Tract Injury

Key principle from Berek & Novak's Gynecology: "Electrosurgery should not be used without proper localization of the ureters. If it is not apparent where the bleeding is occurring, the procedure should be converted to an open one."

5.3 Vascular, Bowel and Other Intraoperative Injuries

• Intraoperative complications include: ureteral injury, bladder injury, bowel injury, hemorrhage, vascular injury
• "The intraoperative complications of a laparoscopic hysterectomy are similar to an open hysterectomy. These are injury to the ureter, bladder, bowel, and hemorrhage. Recognition and management are similar." (Berek & Novak's Gynecology)
• Pooled meta-analyses report intraoperative complication rates of 5.1%-7.1% for laparoscopic radical hysterectomy
• The LACC trial (cervical cancer) reported 11%; SUCCOR study reported 9.3%; neither found significant differences vs. open radical hysterectomy for overall intraoperative complications

5.4 Surgical Site Infection (SSI)

• Smaller incisions (reduced wound surface area)
• Less tissue trauma and devascularization
• Faster recovery of immune function

5.5 Conversion to Open Surgery

5.6 Nerve Injury

• Femoral nerve palsy - from hyperflexion of hips in lithotomy position
• Brachial plexus injury - from shoulder braces (should NOT be used)
• Proper positioning on egg crate mattress/beanbag in steep Trendelenburg minimizes these risks (Berek & Novak's Gynecology)

6. Special Populations

6.1 Obesity

• Obesity is not a contraindication to laparoscopic hysterectomy
• The increased morbidity of laparotomy in high-BMI patients can be minimized with laparoscopy
• For endometrial cancer in obese patients (BMI 30-60), robotics is preferable: shorter operative time, reduced blood loss, shorter hospital stay (Berek & Novak's Gynecology)
• Operating time with robotics remains unchanged despite increasing BMI (absence of haptic feedback means no perceived resistance from thick abdominal wall)

6.2 Large Uteri (>12 weeks / >250 g)

• All minimally invasive routes (vaginal, laparoscopic, robotic) result in lower blood loss and shorter length of stay than open surgery
• Abdominal route has shorter operative time (Mamik et al., Obstet Gynecol, 2024)
• TLH carries significantly higher ureteral injury risk vs. vaginal hysterectomy for large uteri (OR 7.54)

6.3 Gynecologic Malignancy

Endometrial Cancer

• Laparoscopic/robotic hysterectomy is preferred over laparotomy: shorter operative time, reduced blood loss, more lymph nodes harvested, shorter hospital stay
• No significant differences in perioperative complications or recurrence rates

Cervical Cancer - Critical Alert

The LACC trial (randomized, international, multicenter) compared minimally invasive vs. open radical hysterectomy for early cervical cancer (FIGO IA1-IB1):

• Disease-free survival at 3 years: 91.2% (MIS) vs. 97.1% (open) - HR for recurrence/death = 3.74 (95% CI: 1.63-8.58)
• Overall survival at 3 years: 93.8% (MIS) vs. 99.0% (open) - HR for death = 6.00 (95% CI: 1.77-20.30)
• No difference for tumors <2 cm; all recurrences occurred in 14 of 33 centers

For early cervical cancer, open radical hysterectomy remains the oncologic standard. Minimally invasive surgery offers perioperative advantages but at the cost of inferior oncologic outcomes. (Berek & Novak's Gynecology; Kampers et al., 2022)

7. Summary Comparison Table

8. Perioperative Care Considerations

Laparoscopic

• Foley catheter often removed at end of procedure
• Regular diet tolerated on day of surgery
• Preemptive multimodal analgesia: IV acetaminophen, gabapentin, ketorolac
• Same-day or next-day discharge increasingly feasible

Open

• Longer ileus recovery period
• IV analgesia often required for 24-48 hours
• Wound care for abdominal incision
• Average hospital stay 3-5 days

9. Conclusions

References

1. Berek JS, ed. Berek & Novak's Gynecology, 16th ed. (Wolters Kluwer). Chapters 27-28: Hysterectomy approaches, laparoscopic technique, intraoperative complications.
2. Pickett CM, Seeratan DD, Mol BWJ, et al. Surgical approach to hysterectomy for benign gynaecological disease. Cochrane Database Syst Rev. 2023;8:CD003677. [PMID 37642285]
3. Mamik MM, Kim-Fine S, Yang L, et al. Hysterectomy techniques and outcomes for benign large uteri: a systematic review. Obstet Gynecol. 2024;144(1):40-52. [PMID 38743951]
4. Lenfant L, Canlorbe G, Belghiti J, et al. Robotic-assisted benign hysterectomy compared with laparoscopic, vaginal, and open surgery: a systematic review and meta-analysis. J Robot Surg. 2023 Dec. [PMID 37856058]
5. Kampers J, Gerhardt E, Sibbertsen P, et al. Perioperative morbidity of different operative approaches in early cervical carcinoma: a systematic review and meta-analysis. Arch Gynecol Obstet. 2022. [PMID 34625835]
6. Aarts JWM, Nieboer TE, Johnson M, et al. Surgical approach to hysterectomy for benign gynecological disease. Cochrane Database Syst Rev 2015;(8):CD003677. (Historical reference cited in Berek & Novak)

Recent Clinical Guidelines & Evidence on Hysterectomy Approach Selection (2024-2026)

1. Governing Guideline Framework

ACOG Committee Opinion No. 701 - Current Standing Position

1. Vaginal hysterectomy (VH) - approach of choice whenever feasible; associated with better outcomes vs. all other approaches 2. Laparoscopic hysterectomy (LH) - preferred alternative to open when VH is not feasible 3. Open abdominal hysterectomy (AH) - reserved for patients in whom minimally invasive approaches are not indicated or possible

• Vaginal shape, uterine size and shape
• Accessibility to the uterus (descensus, adhesions)
• Extent of extrauterine disease
• Need for concurrent procedures
• Surgeon training, experience, and average case volume
• Available hospital technology
• Whether the case is emergent or elective
• Preference of the informed patient

2. Is Vaginal Hysterectomy Still the "First Choice"? - 2025 Challenge to Conventional Doctrine

• Searched PubMed, Scopus, EMBASE, Cochrane Library (1996-July 2024)
• Key findings:
  • VH has shorter operative time vs. all other approaches
  • VH is associated with reduced admission-to-recovery time vs. laparotomy
  • No differences in intra- or postoperative complication rates between VH and other approaches
  • Evidence quality ranged from critical to moderate, with high heterogeneity
• Conclusion: VH remains clinically relevant and offers reduced operating time and faster recovery with comparable complication rates - but a "nuanced comparison with alternative and innovative techniques is essential for personalized surgical decisions and a potential renaissance of this approach"

Major 2026 National Database Study - Challenging VH Primacy

• VH had higher risks of: blood transfusion, urinary tract infection, organ/space infection, and reoperation
• LH had higher risks of: wound dehiscence and pulmonary embolism

Conclusion: "The study results suggest that vaginal hysterectomy is not clearly a preferred route for hysterectomy over laparoscopic hysterectomy. The data support further investigation of the optimal surgical approach with large, prospective clinical studies."

3. Robotic vs. Conventional Laparoscopic Hysterectomy - 2026 GRADE Assessment

Conclusion: Robotic and conventional laparoscopic hysterectomy demonstrate comparable operative outcomes for benign disease. Robotic offers modestly shorter hospitalization. Given substantial cost differences, conventional laparoscopy remains a clinically equivalent option for most patients.

4. Vaginal Cuff Dehiscence - 2025 Updated Meta-Analysis

5. ESGO-ESTRO-ESP Guidelines for Endometrial Cancer - July 2025

• Total hysterectomy with bilateral salpingo-oophorectomy + lymph node staging
• Minimally invasive surgery should be offered once the patient has completed family planning
• For Lynch syndrome carriers: Hysterectomy + BSO by minimally invasive surgery is the preferred approach, ideally before age 40 in MLH1/MSH2/MSH6 mutation carriers

6. NICE 2024 Guidance (Endometriosis Context)

• Shared decision-making as the cornerstone of hysterectomy decisions
• Choices about hysterectomy and oophorectomy should reflect the patient's preferences, comorbidities, and individual risk tolerance
• Hysterectomy is appropriate for adenomyosis or chronic pelvic pain unresponsive to medical therapy
• Routine oophorectomy is not recommended

7. Summary: Where Guidelines Stand in 2025-2026

8. Key Takeaways for Clinical Practice

1. The vaginal-first hierarchy is being questioned by the largest contemporary real-world dataset (NSQIP, n=83,436), which found LH actually had fewer 30-day complications than VH. Updated guidelines are anticipated.
2. Robotic = Conventional laparoscopic for benign disease on all clinically meaningful outcomes (2026 GRADE meta-analysis). Cost considerations favor conventional laparoscopy.
3. Open surgery remains standard for early cervical cancer (LACC trial) - minimally invasive radical hysterectomy should not be offered for tumors >2 cm.
4. Vaginal cuff dehiscence (unique to MIS hysterectomy) has an overall incidence of 0.7%, with barbed sutures and laparoscopic closure being the preferred preventive technique.
5. Personalized approach is the overarching theme across all 2024-2025 guideline documents - no single route is universally optimal.

References

1. ACOG Committee Opinion No. 701. Choosing the Route of Hysterectomy for Benign Disease. ACOG, 2017 (current standing).
2. Meyer R, et al. Vaginal hysterectomy vs laparoscopic hysterectomy for benign indications. Am J Obstet Gynecol. 2026 Mar. [PMID 41347647]
3. Mirza W, et al. Robotic versus conventional laparoscopic total hysterectomy. J Robot Surg. 2026 Jan. [PMID 41521312]
4. Oliva R, et al. Is vaginal hysterectomy outdated? J Gynecol Obstet Hum Reprod. 2025 Sep. [PMID 40345622]
5. Zorzato PC, et al. Vaginal cuff dehiscence after laparoscopic and robotic hysterectomy. Medicina. 2025. [PMID 40282938]
6. ESGO-ESTRO-ESP Guidelines for Endometrial Cancer. July 2025.
7. NICE 2024 Endometriosis Guidelines (shared decision-making in hysterectomy).